Mouse monoclonal [3G5] to beta AmyloidThe cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid antibodies and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
Immunogen
A 28 amino acid synthetic peptide (human) derived from the b-amyloid peptide.
Key Feature
Clonality
Monoclonal
Isotype
IgG1
Clone Number
3G5
Host Species
Mouse
Tested Applications
ELISAIHCWB
For ELISA: Use at a concentration of 0.5-1.0 μg/ml. For IHC: Use at an assay dependent dilution. For WB: Use at a concentration of 0.1-0.2 μg/ml. Optimal dilutions/concentrations should be determined by the researcher.
Reacts with the 4-5kD b-amyloid peptide (b-AP). High concentrations of antibody will also react with A-a, B-a and g subunits of fibrinogen.
Cellular Localization
Type I membrane protein
Light Chain Type
kappa
Application Notes
For ELISA: Use at a concentration of 0.5-1.0 μg/ml. For IHC: Use at an assay dependent dilution. For WB: Use at a concentration of 0.1-0.2 μg/ml. Optimal dilutions/concentrations should be determined by the researcher.
Additional Information
Form
Liquid
Storage Instructions
Keep as concentrated solution. Store at 4ºC short term. For extended storage aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.